Natera and Susan G. Komen® Announce National Partnership to Accelerate Progress Against Breast Cancer
Business Wire•28/08/2026•11:03 ET
0
Whiz Insights
Natera and Susan G. Komen® Announce National Partnership to Accelerate Progress Against Breast Cancer
The partnership combines Natera's leadership in breast cancer research and personalized molecular residual disease (MRD) testing with Susan G. Komen's global advocacy and patient support network
Get started
Create a free account to read the full story.